CV Sciences (CV Sciences) LT-Debt-to-Total-Asset : 0.00 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is CV Sciences LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. CV Sciences's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.00.

CV Sciences's long-term debt to total assets ratio declined from Mar. 2023 (0.01) to Mar. 2024 (0.00). It may suggest that CV Sciences is progressively becoming less dependent on debt to grow their business.

CV Sciences LT-Debt-to-Total-Asset Historical Data

The historical data trend for CV Sciences's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CV Sciences LT-Debt-to-Total-Asset Chart

CV Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.18

0.16

0.02

0.01

CV Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.01	0.01	0.01	0.01	-

CV Sciences LT-Debt-to-Total-Asset Calculation

CV Sciences's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	0.058	/	9.2
	=	0.01

CV Sciences's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	0.023	/	8.466
	=	0.00

CV Sciences (OTCPK:CVSI) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

CV Sciences LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of CV Sciences's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

CV Sciences (CV Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CV Sciences Inc (OTCPK:CVSI) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

0HRT:UK

Address

9530 Padgett Street, Suite 107, San Diego, CA, USA, 92126

Website

https://www.cvsciences.com

CV Sciences Inc is a consumer wellness company specializing in hemp extracts and other proven, science-backed, natural ingredients and products, which are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). The company also operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based novel therapeutics.

Executives

William Mccorkle	director	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Corroon James Michael Jr.	director	9530 PADGETT STREET, SUITE 107, SAN DIEGO CA 92126
Maroon Joseph C Md	director	2688 S. RAINBOW BLVD., SUITE B, LAS VEGAS NV 89146
Mona Michael Joseph Jr	director	2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Paul Blake	director	145 BRANDYWINE PKWY, WEST CHESTER PA 19380
Douglas Jesse Mackay	officer: Sr VP Scientific/Regulatory	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Joseph D Dowling	officer: Chief Financial Officer	2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Joerg Grasser	officer: CFO	2688 SOUTH RAINBOW BLVD STE B, LAS VEGAS NV 89146
Elizabeth Ann Altman	director	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Terri F Graham	director	C/O JACK IN THE BOX INC, 9330 BALVOA AVE, SAN DIEGO CA 92123
Stephen Martin Schmitz	director	2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Gary Sligar	director	2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
James A Mcnulty	director	C/O CV SCIENCES, INC., 2688 S. RAINBOW BLVD., SUITE B, LAS VEGAS NV 89146
Larry Phillip Raskin	director	1630 FUNNY CIDE DRIVE, WAXHAW NC 28173
Mackay Ventures Inc.	other: Member 10% holding group	6325 S. JONES BOULEVARD #500, LAS VEGAS NV 89118